Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

3

A Study on HBV Precore Mutant in Liver Tissues of Chronic Hepatitis B Patiets

Hae Chul Chung , Yeong Hong Park , Jung Myung Chung

Clin Mol Hepatol. 1996;2(2):145-159.

View: 2333 Download: 14

4

A Case of Hypothyroidism Induced by Alpha - Interferon Therapy for Chronic Hepatitis B

So Young Kwon , Jong Eun Yeon , Sei Hyun Baik , Jin Ho Kim , Young Tae Baik , Kwan Soo Byun , Chang Hong Lee

Clin Mol Hepatol. 1996;2(1):77-81.

View: 2111 Download: 12

Original Article

Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients

Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery

Received December 16, 2023 Accepted March 25, 2024

DOI: https://doi.org/10.3350/cmh.2023.0535 [Accepted]

View: 379 Download: 33

1 | 2 | 3 | 4 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5437	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5409	MAFLD: How is it different from NAFLD?
Viewed By 5295	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3960	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3957	Global incidence and prevalence of nonalcoholic fatty liver disease

+more

MOST CITED (2022-2024)

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 1202

TOTAL : 1800133